Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implications
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implications
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2021-04-28
DOI
10.1080/14728222.2021.1915991
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation
- (2021) Michelle C. Krutein et al. Blood Advances
- Baseline dysmegakaryopoiesis in inherited thrombocytopenia/platelet disorder with predisposition to haematological malignancies
- (2020) Elise Fournier et al. BRITISH JOURNAL OF HAEMATOLOGY
- Histone deacetylase 3 preferentially binds and collaborates with transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML
- (2020) Chun Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The clinical mutatome of core binding factor leukemia
- (2020) Sabrina Opatz et al. LEUKEMIA
- A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia.
- (2020) Laurène Fenwarth et al. BLOOD
- RUNX1 targeted therapy for AML expressing somatic or germline mutation in RUNX1
- (2019) Christopher P Mill et al. BLOOD
- Hematological malignancies and molecular targeting therapy
- (2019) Akira Shimada EUROPEAN JOURNAL OF PHARMACOLOGY
- Checkpoint inhibitors in AML: are we there yet?
- (2019) Arnab Ghosh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
- (2017) Lars Bullinger et al. JOURNAL OF CLINICAL ONCOLOGY
- RUNX1 cooperates with FLT3-ITD to induce leukemia
- (2017) Kira Behrens et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells
- (2017) D T Saenz et al. LEUKEMIA
- A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells
- (2017) Zaw Min Oo et al. LEUKEMIA & LYMPHOMA
- MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia
- (2017) K H M Prange et al. ONCOGENE
- ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
- (2017) Jean-Baptiste Micol et al. Nature Communications
- Comprehensive mutational profiling of core binding factor acute myeloid leukemia
- (2016) N. Duployez et al. BLOOD
- RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature
- (2016) V.-P. Lavallee et al. BLOOD
- RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features
- (2016) V I Gaidzik et al. LEUKEMIA
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia
- (2016) Lin Fu et al. Oncotarget
- Preclinical study of cinobufagin as a promising anti-colorectal cancer agent
- (2016) Xing-sheng Lu et al. Oncotarget
- Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
- (2016) Anuradha Illendula et al. EBioMedicine
- Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells
- (2015) Xiongwei Cai et al. Cell Stem Cell
- Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial
- (2015) C. Willekens et al. HAEMATOLOGICA
- Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice
- (2015) R K Hyde et al. LEUKEMIA
- Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia
- (2015) I Antony-Debré et al. LEUKEMIA
- Mediator kinase inhibition further activates super-enhancer-associated genes in AML
- (2015) Henry E. Pelish et al. NATURE
- Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
- (2015) Philipp Rathert et al. NATURE
- BET inhibitor resistance emerges from leukaemia stem cells
- (2015) Chun Yew Fong et al. NATURE
- A small-molecule inhibitor of the aberrant transcription factor CBF -SMMHC delays leukemia in mice
- (2015) A. Illendula et al. SCIENCE
- Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial
- (2015) C. Willekens et al. HAEMATOLOGICA
- Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia
- (2015) Kate H. Brettingham-Moore et al. Frontiers in Immunology
- Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)
- (2015) Harald Herrmann et al. Oncotarget
- Downregulation of RUNX1/CBF by MLL fusion proteins enhances hematopoietic stem cell self-renewal
- (2014) X. Zhao et al. BLOOD
- Posttranslational modifications of RUNX1 as potential anticancer targets
- (2014) S Goyama et al. ONCOGENE
- Comprehensive mutational profiling in advanced systemic mastocytosis
- (2013) J. Schwaab et al. BLOOD
- Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia
- (2013) E. Jourdan et al. BLOOD
- Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells
- (2013) Susumu Goyama et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
- (2013) Raphaël Itzykson et al. JOURNAL OF CLINICAL ONCOLOGY
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
- (2013) T Haferlach et al. LEUKEMIA
- RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction
- (2013) Adam C. Wilkinson et al. Cell Reports
- Addiction of t(8;21) and inv(16) Acute Myeloid Leukemia to Native RUNX1
- (2013) Oren Ben-Ami et al. Cell Reports
- Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial
- (2012) J. A. L. Yin et al. BLOOD
- RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes
- (2012) P. A. Greif et al. HAEMATOLOGICA
- RUNX family: Regulation and diversification of roles through interacting proteins
- (2012) Linda Shyue Huey Chuang et al. INTERNATIONAL JOURNAL OF CANCER
- RUNX1Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures
- (2012) Jason H. Mendler et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBF interaction
- (2012) L. Cunningham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations
- (2011) G. Huang et al. BLOOD
- Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects
- (2011) Susumu Goyama et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
- (2011) Ching-Hon Pui et al. JOURNAL OF CLINICAL ONCOLOGY
- RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
- (2011) Verena I. Gaidzik et al. JOURNAL OF CLINICAL ONCOLOGY
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- AML1/RUNX1 gene point mutations in childhood myeloid malignancies
- (2011) Alexandr Migas et al. PEDIATRIC BLOOD & CANCER
- In vivo toxicological evaluation of Anisomycin
- (2011) Zhengle Tang et al. TOXICOLOGY LETTERS
- RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis
- (2010) S. Schnittger et al. BLOOD
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
- (2010) Julien Rocquain et al. BMC CANCER
- RUNX1translocations and fusion genes in malignant hemopathies
- (2010) Etienne De Braekeleer et al. Future Oncology
- A Runx1 Intronic Enhancer Marks Hemogenic Endothelial Cells and Hematopoietic Stem Cells
- (2010) Cherry Ee Lin Ng et al. STEM CELLS
- AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations
- (2009) J.-L. Tang et al. BLOOD
- Narciclasine, a plant growth modulator, activates Rho and stress fibers in glioblastoma cells
- (2009) F. Lefranc et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now